Zika among international travellers presenting to GeoSentinel sites, 2012-2019: implications for clinical practice
Open Access
- 25 April 2020
- journal article
- research article
- Published by Oxford University Press (OUP) in Journal of Travel Medicine
- Vol. 27 (4)
- https://doi.org/10.1093/jtm/taaa061
Abstract
Introduction: International travellers contribute to the rapid spread of Zika virus (ZIKV) and its sentinel identification globally. We describe ZIKV infections among international travellers seen at GeoSentinel sites with a focus on ZIKV acquired in the Americas and the Caribbean, describe countries of exposure and traveller characteristics, and assess ZIKV diagnostic testing by site. Methods: Records with an international travel-related diagnosis of confirmed or probable ZIKV from January 2012 through December 2019 reported to GeoSentinel with a recorded illness onset date were included to show reported cases over time. Records from March 2016 through December 2019 with an exposure region of the Americas or the Caribbean were included in the descriptive analysis. A survey was conducted to assess the availability, accessibility and utilization of ZIKV diagnostic tests at GeoSentinel sites. Results: GeoSentinel sites reported 525 ZIKV cases from 2012 through 2019. Between 2012 and 2014, eight cases were reported, and all were acquired in Asia or Oceania. After 2014, most cases were acquired in the Americas or the Caribbean, a large decline in ZIKV cases occurred in 2018-19. Between March 2016 and December 2019, 423 patients acquired ZIKV in the Americas or the Caribbean, peak reporting to these regions occurred in 2016 [330 cases (78%)]. The median age was 36 years (range: 3-92); 63% were female. The most frequent region of exposure was the Caribbean (60%). Thirteen travellers were pregnant during or after travel; one had a sexually acquired ZIKV infection. There was one case of fetal anomaly and two travellers with Guillain-Barre syndrome. GeoSentinel sites reported various challenges to diagnose ZIKV effectively. Conclusion: ZIKV should remain a consideration for travellers returning from areas with risk of ZIKV transmission. Travellers should discuss their travel plans with their healthcare providers to ensure ZIKV prevention measures are taken.Funding Information
- International Society of Travel Medicine
- Cooperative Agreement (U50CK00189)
- Centers for Disease Control and Prevention
- European Union’s Horizon 2020 Research and Innovation Program (734584)
This publication has 27 references indexed in Scilit:
- Zika virus in AsiaInternational Journal of Infectious Diseases, 2016
- How Relevant Is Sexual Transmission of Zika Virus?PLoS Medicine, 2016
- Potential for Zika virus introduction and transmission in resource-limited countries in Africa and the Asia-Pacific region: a modelling studyThe Lancet Infectious Diseases, 2016
- Zika virus infection in two travelers returning from an epidemic area to Italy, 2016: Algorithm for diagnosis and recommendationsTravel Medicine and Infectious Disease, 2016
- Non-vector-borne transmission of Zika virus: A systematic reviewTravel Medicine and Infectious Disease, 2016
- Zika VirusClinical Microbiology Reviews, 2016
- Estimated global exportations of Zika virus infections via travellers from Brazil from 2014 to 2015:Journal of Travel Medicine, 2016
- Zika virus and microcephaly: why is this situation a PHEIC?The Lancet, 2016
- Zika Virus Infection Acquired During Brief Travel to IndonesiaThe American Journal of Tropical Medicine and Hygiene, 2013
- Zika Virus Outbreak on Yap Island, Federated States of MicronesiaThe New England Journal of Medicine, 2009